Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
Baxter
Healthtrust
Harvard Business School
Teva
Daiichi Sankyo
McKinsey
Argus Health
Julphar

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011559

« Back to Dashboard

NDA 011559 describes BREVITAL SODIUM, which is a drug marketed by Par Sterile Products and is included in one NDA. It is available from one supplier. Additional details are available on the BREVITAL SODIUM profile page.

The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methohexital sodium profile page.
Summary for 011559
Tradename:BREVITAL SODIUM
Applicant:Par Sterile Products
Ingredient:methohexital sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 011559
Ingredient-typeBarbiturates
Medical Subject Heading (MeSH) Categories for 011559
Suppliers and Packaging for NDA: 011559
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559 NDA Par Pharmaceutical, Inc. 42023-105 N 42023-105-01
BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559 NDA Par Pharmaceutical, Inc. 42023-106 N 42023-106-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.5GM/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5GM/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Army
Accenture
Moodys
AstraZeneca
US Department of Justice
Boehringer Ingelheim
Fish and Richardson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot